Foundation Medicine, Inc. is a molecular diagnostics company focused on comprehensive genomic profiling (CGP) for cancer to help physicians match patients with targeted therapies, immunotherapies, and clinical trials. The company offers tissue- and liquid-based next-generation sequencing (NGS) tests and partners with biopharmaceutical companies to support oncology drug development and companion diagnostics. It operates as a wholly owned subsidiary of Roche.
This is about using very smart pattern-finding computers to read our genes and medical data so doctors can pick the right drug and dose for each person, instead of treating everyone the same.
This is like giving oncologists a super-assistant that can read many different kinds of medical information at once—genomic profiles, imaging, lab results, and clinical notes—and then suggest patterns, risks, and treatment options that would be hard for any one human to spot alone.